Brown Brothers Harriman & Co’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,015
| Closed | -$530K | – | 1853 |
|
|
2026
Q1 | $530K | Buy |
7,015
+914
| +15% | +$68.7K | ﹤0.01% | 586 |
|
|
2025
Q4 | $454K | Buy |
6,101
+1,423
| +30% | +$104K | ﹤0.01% | 559 |
|
|
2025
Q3 | $316K | Buy |
4,678
+428
| +10% | +$28.4K | ﹤0.01% | 591 |
|
|
2025
Q2 | $277K | Buy |
4,250
+545
| +15% | +$32.7K | ﹤0.01% | 567 |
|
|
2025
Q1 | $229K | Buy |
3,705
+54
| +1% | +$3.58K | ﹤0.01% | 535 |
|
|
2024
Q4 | $263K | Buy |
3,651
+36
| +1% | +$2.81K | ﹤0.01% | 526 |
|
|
2024
Q3 | $294K | Hold |
3,615
| – | – | ﹤0.01% | 518 |
|
|
2024
Q2 | $268K | Hold |
3,615
| – | – | ﹤0.01% | 492 |
|
|
2024
Q1 | $282K | Hold |
3,615
| – | – | ﹤0.01% | 463 |
|
|
2023
Q4 | $258K | Hold |
3,615
| – | – | ﹤0.01% | 454 |
|
|
2023
Q3 | $251K | Sell |
3,615
-14
| -0.4% | -$1.06K | ﹤0.01% | 446 |
|
|
2023
Q2 | $294K | Hold |
3,629
| – | – | ﹤0.01% | 410 |
|
|
2023
Q1 | $293K | Hold |
3,629
| – | – | ﹤0.01% | 415 |
|
|
2022
Q4 | $271K | Sell |
3,629
-1,051
| -22% | -$74.8K | ﹤0.01% | 408 |
|
|
2022
Q3 | $302K | Buy |
4,680
+916
| +24% | +$63.5K | ﹤0.01% | 377 |
|
|
2022
Q2 | $261K | Buy |
3,764
+51
| +1% | +$3.79K | ﹤0.01% | 421 |
|
|
2022
Q1 | $285K | Buy |
3,713
+3,615
| +3,689% | +$260K | ﹤0.01% | 437 |
|
|
2021
Q4 | $8 | Hold |
98
| – | – | ﹤0.01% | 952 |
|
|
2021
Q3 | $7 | Hold |
98
| – | – | ﹤0.01% | 953 |
|
|
2021
Q2 | $7 | Sell |
98
-36
| -27% | -$2.41K | ﹤0.01% | 944 |
|
|
2021
Q1 | $10 | Sell |
134
-1,817
| -93% | -$138K | ﹤0.01% | 863 |
|
|
2020
Q4 | $142K | Buy |
1,951
+1,485
| +319% | +$105K | ﹤0.01% | 494 |
|
|
2020
Q3 | $31K | Buy |
466
+436
| +1,453% | +$27.6K | ﹤0.01% | 636 |
|
|
2020
Q2 | $2K | Buy |
30
+15
| +100% | +$736 | ﹤0.01% | 891 |
|
|
2020
Q1 | $1K | Buy |
+15
| New | +$714 | ﹤0.01% | 1006 |
|
|
2019
Q4 | – | Sell |
-1,261
| Closed | -$64K | – | 1179 |
|
|
2019
Q3 | $64K | Hold |
1,261
| – | – | ﹤0.01% | 606 |
|
|
2019
Q2 | $61K | Buy |
+1,261
| New | +$58.3K | ﹤0.01% | 558 |
|
|
2019
Q1 | – | Sell |
-62
| Closed | -$3K | – | 1052 |
|
|
2018
Q4 | $3K | Buy |
+62
| New | +$2.54K | ﹤0.01% | 825 |
|
|
2016
Q3 | – | Sell |
-500
| Closed | -$17K | – | 795 |
|
|
2016
Q2 | $17K | Buy |
+500
| New | +$17.3K | ﹤0.01% | 571 |
|
|
2014
Q2 | – | Sell |
-600
| Closed | -$13K | – | 772 |
|
|
2014
Q1 | $13K | Hold |
600
| – | – | ﹤0.01% | 648 |
|
|
2013
Q4 | $13K | Buy |
+600
| New | +$13.2K | ﹤0.01% | 574 |
|
|
2013
Q3 | – | Sell |
-416
| Closed | -$8K | – | 739 |
|
|
2013
Q2 | $8K | Buy |
+416
| New | +$8.69K | ﹤0.01% | 661 |
|
Other funds holding HOLX
Brown Brothers Harriman & Co's HOLX Position: Q2 2026 in Review
Brown Brothers Harriman & Co sold out of Hologic (HOLX) in Q2 2026, closing a stake of 7,015 shares — an estimated $530K sold.
Brown Brothers Harriman & Co first reported a position in HOLX in Q2 2013 and held it in 32 quarters. The position peaked at $530K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Brown Brothers Harriman & Co reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Brown Brothers Harriman & Co sold 7,015 Hologic shares in Q2 2026, an estimated $530K.
- Brown Brothers Harriman & Co first reported a position in Hologic in Q2 2013 and held it in 32 quarters.
- Brown Brothers Harriman & Co's Hologic position peaked at $530K in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.